Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain

Camilla Kristine Appel; Simone Gallego-Pedersen; Line Andersen; Sophie Blancheflor Kristensen; Ming Ding; Sarah Falk; Manasi Sayilekshmy; Charlotte Gabel-Jensen; Anne-Marie Heegaard

doi:10.1038/s41598-019-43721-6

Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain

Sci Rep. 2019 May 9;9(1):7399. doi: 10.1038/s41598-019-43721-6.

Authors

Camilla Kristine Appel¹, Simone Gallego-Pedersen¹, Line Andersen¹, Sophie Blancheflor Kristensen¹, Ming Ding², Sarah Falk¹, Manasi Sayilekshmy¹, Charlotte Gabel-Jensen³, Anne-Marie Heegaard⁴

Affiliations

¹ University of Copenhagen, Faculty of Health and Medical Sciences, Department of Drug Design and Pharmacology, Copenhagen, 2100, Denmark.
² Odense University Hospital, University of Southern Denmark, Institute of Clinical Research, Department of Orthopaedics and Traumatology, Odense, 5320, Denmark.
³ University of Copenhagen, Faculty of Health and Medical Sciences, Department of Pharmacy, Copenhagen, 2100, Denmark.
⁴ University of Copenhagen, Faculty of Health and Medical Sciences, Department of Drug Design and Pharmacology, Copenhagen, 2100, Denmark. amhe@sund.ku.dk.

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Publication types

Published Erratum